ACS Omega (May 2021)
Stabilization of an 211At-Labeled Antibody with Sodium Ascorbate
- Shino Manabe,
- Hiroki Takashima,
- Kazunobu Ohnuki,
- Yoshikatsu Koga,
- Ryo Tsumura,
- Nozomi Iwata,
- Yang Wang,
- Takuya Yokokita,
- Yukiko Komori,
- Sachiko Usuda,
- Daiki Mori,
- Hiromitsu Haba,
- Hirofumi Fujii,
- Masahiro Yasunaga,
- Yasuhiro Matsumura
Affiliations
- Shino Manabe
- Pharmaceutical Department, Hoshi University, Tokyo, Japan
- Hiroki Takashima
- Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Kazunobu Ohnuki
- Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Yoshikatsu Koga
- Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Ryo Tsumura
- Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Nozomi Iwata
- Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Yang Wang
- Nishina Center for Accelerator-Based Science, RIKEN, Wako-shi, Saitama, Japan
- Takuya Yokokita
- Nishina Center for Accelerator-Based Science, RIKEN, Wako-shi, Saitama, Japan
- Yukiko Komori
- Nishina Center for Accelerator-Based Science, RIKEN, Wako-shi, Saitama, Japan
- Sachiko Usuda
- Nishina Center for Accelerator-Based Science, RIKEN, Wako-shi, Saitama, Japan
- Daiki Mori
- Nishina Center for Accelerator-Based Science, RIKEN, Wako-shi, Saitama, Japan
- Hiromitsu Haba
- Nishina Center for Accelerator-Based Science, RIKEN, Wako-shi, Saitama, Japan
- Hirofumi Fujii
- Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Masahiro Yasunaga
- Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa City, Japan
- Yasuhiro Matsumura
- Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan
- DOI
- https://doi.org/10.1021/acsomega.1c00684
- Journal volume & issue
-
Vol. 6,
no. 23
pp. 14887 – 14895
Abstract
No abstracts available.